An article authored by Avacta Diagnostic’s Commercial Director David Wilson, features in this month’s European Biopharmaceutical Review.
You can view a copy HERE.
This article is taken from European Biopharmaceutical Review January 2022, pages 40-43. © Samedan Ltd.